Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-05-26 18:00:27 ET · period of report 2026-05-21 · accession 0002048466-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-05-26 18:00 | 2026-05-21+ | BBNX | Lezack Adam | Dir | S - Sale | $10.58 | -1,998 | 27.4K | -7% | -$21.1K |
| T | 2026-05-26 18:00 | 2026-05-21 | BBNX | Lezack Adam | Dir | A - Grant | $0.00 | +17.0K | 28.4K | +148% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | S | D | 1,000 | $9.95 | 11,432 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. |
| 2 | Common | Common Stock | 2026-05-21 | A | A | 16,965 | $0.00 | 28,397 | D | — | — | (F2) Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. |
| 3 | Common | Comon Stock | 2026-05-22 | S | D | 998 | $11.21 | 27,399 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. |